Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Oncotarget|September 10, 2016
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapySilvia Darb-Esfahani, Carsten Denkert, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|March 9, 2021
KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreasDaniel Schmitz, Daniel Kazdal, Michael Allgäuer, et al.
Seminars in Oncology|December 18, 2017
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer PatientsEttore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, et al.
Genes, Chromosomes & Cancer|October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assaysNicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.
Genes, Chromosomes & Cancer|July 31, 2021
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicinePeter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical fieldAnna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
International Journal of Cancer|January 18, 2019
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg casesAnna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2012
Srgap3⁻/⁻ mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypesRobert Waltereit, Uwe Leimer, Oliver von Bohlen Und Halbach, et al.
Pageof 12